| Bioactivity | GLP-1 receptor agonist 8 is a potent agonist of GLP-1 R. GLP-1 receptor agonist 8 has the potential for the research of diabetes, obesity, and nonalcoholic fatty liver disease (NAFLD) (extracted from patent WO2019239319A1, compound 17)[1]. |
| Target | GLP-1 R |
| Name | GLP-1 receptor agonist 8 |
| CAS | 2401892-86-0 |
| Formula | C34H36ClFN6O4 |
| Molar Mass | 647.14 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Gary Erik Aspnes, et al. Glp-1 receptor agonists and uses thereof. Patent WO2019239319A1. |
GLP-1 receptor agonist 8
CAS: 2401892-86-0 F: C34H36ClFN6O4 W: 647.14
GLP-1 receptor agonist 8 is a potent agonist of GLP-1 R. GLP-1 receptor agonist 8 has the potential for the research of
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.